Discovery and Preclinical Evaluations of Potent, Selective, and Allosteric Covalent WRN Inhibitors with Improved PK Properties.
- DOI
- 10.1021/acsmedchemlett.5c00787
- Published
- 2026 Feb 12
- Container
- ACS medicinal chemistry letters
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acsmedchemlett.5c00787,
title = {Discovery and Preclinical Evaluations of Potent, Selective, and Allosteric Covalent WRN Inhibitors with Improved PK Properties.},
author = {Xu Z and Xiao Q and Liu Y and Jiang W and Liu L and Sun H and Yang X and Lu Z and Yan B and Long H and Zhang X},
year = {2026},
journal = {ACS medicinal chemistry letters},
doi = {10.1021/acsmedchemlett.5c00787},
url = {https://doi.org/10.1021/acsmedchemlett.5c00787}
}RIS
TY - JOUR TI - Discovery and Preclinical Evaluations of Potent, Selective, and Allosteric Covalent WRN Inhibitors with Improved PK Properties. AU - Xu Z AU - Xiao Q AU - Liu Y AU - Jiang W AU - Liu L AU - Sun H AU - Yang X AU - Lu Z AU - Yan B AU - Long H AU - Zhang X PY - 2026 JO - ACS medicinal chemistry letters DO - 10.1021/acsmedchemlett.5c00787 UR - https://doi.org/10.1021/acsmedchemlett.5c00787 ER -
APA
Z, X., Q, X., Y, L., W, J., L, L., H, S., X, Y., Z, L., B, Y., H, L., & X, Z. (2026). Discovery and Preclinical Evaluations of Potent, Selective, and Allosteric Covalent WRN Inhibitors with Improved PK Properties.. ACS medicinal chemistry letters. https://doi.org/10.1021/acsmedchemlett.5c00787
Source records
- pubmed · retrieved 2026-09-26T21:27:16.537Z